3 buy-rated ASX shares

Here are three quality ASX shares rated as buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the Australian share market, it can be hard to decide which ones to buy over others.

To narrow things down, I have picked out three options that are highly rated to consider:

stack of wooden blocks with '1, 2, 3' written on them

Image source: Getty Images

Pushpay Holdings Group Ltd (ASX: PPH)

The first ASX share to look at is Pushpay. It is a leading donor management and community engagement platform provider for the faith sector. Pushpay has also boosted its offering with acquisitions. The most recent being the US$150 million acquisition of Resi Media. It is a US-based market-leading streaming solutions provider, servicing more than 70% of the Outreach 100 largest churches in the US. Management notes that it broadens Pushpay's core product offering and enhances its value proposition to customers, strengthening its digital technology strategy and maintaining its position at the forefront of innovation in the faith sector.

Jarden currently has a buy rating and NZ$2.24 (A$2.15) price target on its shares.

ResMed Inc. (ASX: RMD)

Another ASX share to look at is ResMed. It is a medical device company with a focus on the sleep treatment market. Thanks to its industry-leading products, wide distribution network, and successful acquisitions, ResMed has been growing at a very strong rate over the last few years. The good news is that thanks to its significant market opportunity and the growing prevalence of sleep disorders, it has been tipped to continue doing so for the foreseeable future. Its near term performance is also being boosted by a major product recall from a competitor.

Morgans is positive on the company and has an add rating and $40.80 price target on ResMed's shares.

Zip Co Ltd (ASX: Z1P)

A final ASX share to look at is Zip. This buy now pay later (BNPL) provider has been growing at a strong rate over the last few years thanks to the increasing popularity of the payment method and its international expansion. This has continued in FY 2022, with Zip recently revealing record quarterly revenue of $136.8 million during the first quarter. This was up 89% year on year and 8% quarter on quarter. The good news is the company still has a very long runway for growth over the next decade thanks to its massive global market opportunity.

Analysts at Morgans are positive on Zip. They currently have an add rating and $8.56 price target on its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended PUSHPAY FPO NZX and ZIPCOLTD FPO. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia owns shares of and has recommended PUSHPAY FPO NZX. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Growth Shares

Down 35%+, should you buy Zip and WiseTech shares?

Let's look at two fallen ASX growth shares that still have long-term opportunities.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Growth Shares

3 ASX tech stocks tipped to rocket higher in FY27

Xero, Megaport, and Life360 are three ASX tech stocks that brokers think could rocket higher in FY27. Here is the…

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 fantastic ASX growth shares to buy to build real wealth

Looking to build wealth? These shares could help you do it.

Read more »

A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
ASX Share Market News

These ASX growth shares are up 40%. Can they keep climbing?

Strong execution and broker optimism continue supporting both growth stories.

Read more »

A blockchain investor sits at his desk with a laptop computer open and a phone checking information from a booklet in a home office setting.
Growth Shares

3 super ASX shares that could be too good to ignore in July

It could be a good time to consider a position in these shares.

Read more »

A young man goes over his finances and investment portfolio at home.
Growth Shares

Where to invest $10,000 in ASX shares in July

Looking for options for next month? Here are three to consider.

Read more »

Businessman studying a high technology holographic stock market chart.
Growth Shares

Why this analyst rates Life360 shares a buy right now

Life360 shares are down 29% in 2026, but Bell Potter has a buy rating on the stock.

Read more »

A boy sits on his dad's shoulders, both are flexing their biceps in unison.
Growth Shares

2 ASX 200 shares I'd buy for powerful growth

I like software businesses that become harder to replace as customers rely on them more deeply.

Read more »